US FTC extends public comment period on pharmacy benefit manager's practices
MLex Summary: The US Federal Trade Commission has extended the public comment period on a request for information on the ways that practices by large, vertically integrated pharmacy benefit managers, which manage...To view the full article, register now.
Already a subscriber? Click here to view full article